The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Analyzes adverse events in clinical trials using the 'metalite' data structure. The package simplifies the workflow to create production-ready tables, listings, and figures discussed in the adverse events analysis chapters of "R for Clinical Study Reports and Submission" by Zhang et al. (2022) <https://r4csr.org/>.
| Version: | 0.1.2 |
| Depends: | R (≥ 4.1.0) |
| Imports: | glue, metalite, r2rtf, stats |
| Suggests: | DescTools, covr, dplyr, knitr, rmarkdown, testthat (≥ 3.0.0), tibble, tidyr |
| Published: | 2024-04-16 |
| Author: | Yilong Zhang [aut], Yujie Zhao [aut, cre], Benjamin Wang [aut], Nan Xiao [aut], Sarad Nepal [aut], Madhusudhan Ginnaram [aut], Venkatesh Burla [ctb], Ruchitbhai Patel [aut], Brian Lang [aut], Xuan Deng [aut], Hiroaki Fukuda [aut], Bing Liu [aut], Merck Sharp & Dohme Corp [cph] |
| Maintainer: | Yujie Zhao <yujie.zhao at merck.com> |
| BugReports: | https://github.com/Merck/metalite.ae/issues |
| License: | GPL-3 |
| URL: | https://merck.github.io/metalite.ae/, https://github.com/Merck/metalite.ae |
| NeedsCompilation: | no |
| Materials: | README NEWS |
| CRAN checks: | metalite.ae results |
| Package source: | metalite.ae_0.1.2.tar.gz |
| Windows binaries: | r-devel: metalite.ae_0.1.2.zip, r-release: metalite.ae_0.1.2.zip, r-oldrel: metalite.ae_0.1.2.zip |
| macOS binaries: | r-release (arm64): metalite.ae_0.1.2.tgz, r-oldrel (arm64): metalite.ae_0.1.2.tgz, r-release (x86_64): metalite.ae_0.1.2.tgz, r-oldrel (x86_64): metalite.ae_0.1.2.tgz |
| Old sources: | metalite.ae archive |
| Reverse imports: | forestly |
Please use the canonical form https://CRAN.R-project.org/package=metalite.ae to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.